| Literature DB >> 28611043 |
Jia Shao1, Linlin Xu1, Limin Chen1, Quqin Lu2, Xinsheng Xie1, Wei Shi1, Huanting Xiong1, Chao Shi1, Xuan Huang1, Jinhong Mei3, Hai Rao4, Hua Lu5, Nonghua Lu6, Shiwen Luo7.
Abstract
Inhibitors of the Hedgehog (Hh) pathway transducer Smoothened (Smo) have been approved for cancer treatment, but Smo mutations often lead to tumor resistance and it remains unclear how Smo is regulated. In this study, we identified the small GTPase Arl13b as a novel partner and regulator of Smo. Arl13b regulated Smo stability, trafficking, and localization, which are each crucial for Hh signaling. In gastric cancer cells, Arl13b stimulated proliferation, migration, and invasion in vitro and in vivo In clinical specimens of gastric cancer, Arl13b expression correlated strongly with tumor size and depth of invasion; patients with high levels of Arl13b had a poor prognosis. Our results show how Arl13b participates in Hh pathway activation in gastric cancer. Cancer Res; 77(15); 4000-13. ©2017 AACR. ©2017 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28611043 PMCID: PMC5540784 DOI: 10.1158/0008-5472.CAN-16-2461
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701